Search

You searched for "perimetry"

1455 results found

SCOPE Announces 2025 Independent Prescriber Bursary Award Winners

5 August 2025 | Company Profiles, Awards, Conferences & Anniversaries
SCOPE is proud to announce the winners of its 2025 Independent Prescriber (IP) Bursary Awards, an initiative now in its fourth year. Designed to support optometrists in gaining IP qualifications by covering course fees, the awards continue to attract strong...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...
Ophthalmologica journal front cover image.

ILM peeling in proliferative diabetic retinopathy: a meta-analysis

3 April 2026 | | EYE - Vitreo-Retinal
This meta-analysis highlights the efficacy of internal limiting membrane (ILM) peeling on treating posterior segment complications other than macular oedema in patients with proliferative diabetic retinopathy (PDR) treated with vitrectomy. PubMed, EMBASE and Cochrane Library were searched for databases. Eleven...
Ophthalmologica journal front cover image.

Comparison of the efficacy of anti-VEGFs agents in nvAMD

1 June 2026 | | EYE - Vitreo-Retinal
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...

My experience of the transition into a specialist orthoptist role

1 August 2018 | | EYE - General
Michelle Dent discusses the process of transitioning into a new role and the pros and cons along the way. An opportunity arose for a permanent, full time, band 7 specialist role in the medical retina (MR) team in the Newcastle...

Effective management of dry eye and ocular surface disease

4 August 2021 | | EYE - General
Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...

Practice tips: Directions in cataract surgery services and preventing postcataract endophthalmitis

1 August 2015 | | EYE - Cataract, EYE - Refractive
Future directions in the delivery of high quality cataract surgery services and approved intracameral prophylactic approaches to lowering the risk of postcataract infective endophthalmitis were debated by consultant ophthalmic surgeons in a recent London seminar, held at the Royal Society...

Simulated ocular surgery: pars plana vitrectomy and scleral buckling surgery

1 August 2015 | | EYE - Oculoplastic, EYE - Orbit
See also Simulated ocular surgery and Simulated ocular surgery - strabismus surgery In this second article on ocular surgery simulation, we will discuss how vitreoretinal surgery can be simulated using high tech virtual reality modalities such as the Eyesi, as...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Simulating the visual impairment symptoms of age-related macular degeneration in virtual reality

5 June 2023 | | EYE - Vitreo-Retinal
A new virtual reality application visually simulates age-related macular degeneration and demonstrates its progression over time including some Charles Bonnet syndrome hallucinations. Introduction Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries with the prevalence of...

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

23 May 2019 |
Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...

The Eyes Have It launches new report calling for a National Eye Care Plan for England to address surging patient demand

13 December 2023 | England, NHS, Eyecare, Patients, TEHI, WEHD
The Eyes Have It is a partnership of Macular Society, Fight for Sight / Vision Foundation, Royal National Institute of Blind People (RNIB), Association of Optometrists, The Royal College of Ophthalmologists and Roche Products Ltd.